Terms: = Pancreatic cancer AND CBFA2T3, ETO2, 863, ENSG00000129993, ZMYND4, MTGR2, MTG16 AND Diagnosis
9 results:
1. A blood-based metabolomic signature predictive of risk for pancreatic cancer.
Irajizad E; Kenney A; Tang T; Vykoukal J; Wu R; Murage E; Dennison JB; Sans M; Long JP; Loftus M; Chabot JA; Kluger MD; Kastrinos F; Brais L; Babic A; Jajoo K; Lee LS; Clancy TE; Ng K; Bullock A; Genkinger JM; Maitra A; Do KA; Yu B; Wolpin BM; Hanash S; Fahrmann JF
Cell Rep Med; 2023 Sep; 4(9):101194. PubMed ID: 37729870
[TBL] [Abstract] [Full Text] [Related]
2. Epidemiology and survival outcomes of synchronous and metachronous brain metastases: a retrospective population-based study.
Jiang K; Parker M; Materi J; Azad TD; Kamson DO; Kleinberg L; Ye X; Rincon-Torroella J; Bettegowda C
Neurosurg Focus; 2023 Aug; 55(2):E3. PubMed ID: 37527669
[TBL] [Abstract] [Full Text] [Related]
3. Pancreatogenic Diabetes after Partial Pancreatectomy: A Common and Understudied Cause of Morbidity.
Hamad A; Hyer JM; Thayaparan V; Salahuddin A; Cloyd JM; Pawlik TM; Ejaz A
J Am Coll Surg; 2022 Dec; 235(6):838-845. PubMed ID: 36102556
[TBL] [Abstract] [Full Text] [Related]
4. Performance of SPINK1 and SPINK1-based diagnostic model in detection of hepatocellular carcinoma.
Wang F; Liu H; Bai Y; Li H; Wang Z; Xu X
J Clin Lab Anal; 2021 Nov; 35(11):e24025. PubMed ID: 34569662
[TBL] [Abstract] [Full Text] [Related]
5. Brush Cytology, Forceps Biopsy, or Endoscopic Ultrasound-Guided Sampling for diagnosis of Bile Duct cancer: A Meta-Analysis.
Yoon SB; Moon SH; Ko SW; Lim H; Kang HS; Kim JH
Dig Dis Sci; 2022 Jul; 67(7):3284-3297. PubMed ID: 34263382
[TBL] [Abstract] [Full Text] [Related]
6. Low Serum miR-607 Level as a Potential Diagnostic and Prognostic Biomarker in Patients of pancreatic Ductal Adenocarcinoma: A Preliminary Study.
Jiang D; Yuan X; Ni J; Shen L; Cai M; Xu L
Can J Gastroenterol Hepatol; 2021; 2021():8882129. PubMed ID: 34222137
[TBL] [Abstract] [Full Text] [Related]
7. Characteristics of genomic alterations in Chinese cholangiocarcinoma patients.
Jiang G; Zhang W; Wang T; Ding S; Shi X; Zhang S; Shi W; Liu A; Zheng S
Jpn J Clin Oncol; 2020 Sep; 50(10):1117-1125. PubMed ID: 32533190
[TBL] [Abstract] [Full Text] [Related]
8. diagnosis of pancreatic carcinoma based on combined measurement of multiple serum tumor markers using artificial neural network analysis.
Yang Y; Chen H; Wang D; Luo W; Zhu B; Zhang Z
Chin Med J (Engl); 2014; 127(10):1891-6. PubMed ID: 24824251
[TBL] [Abstract] [Full Text] [Related]
9. Evaluating the utility of existing patient-reported outcome scales in novel patient populations with pancreatic cancer, lung cancer, and myeloproliferative neoplasms using medicare current beneficiary survey data.
Ivanova JI; Mytelka DS; Duh MS; Birnbaum HG; Cummings AK; San Roman AM; Price GL; Swindle RW
Patient; 2013; 6(3):189-200. PubMed ID: 23828691
[TBL] [Abstract] [Full Text] [Related]
